Network pharmacology study on the mechanism of berberine in Alzheimer’s disease model
Abstract Research indicated that berberine (BBR) plays a protective role in modulating Alzheimer’s disease (AD). This study aimed to explore the target genes of BBR associated with AD therapy using a network pharmacology study. Through network pharmacology analysis, two main potential target genes,...
Saved in:
Main Authors: | Yaoyi Zhang, Shuai Lv, Pinyuan Huang, Lingmin Xiao, Nan Lin, En Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | npj Science of Food |
Online Access: | https://doi.org/10.1038/s41538-025-00378-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Basis of Inhibitory Activities of Berberine against Pathogenic Enzymes in Alzheimer's Disease
by: Hong-Fang Ji, et al.
Published: (2012-01-01) -
Network pharmacology and experimental verification to investigate the mechanism of isoliquiritigenin for the treatment of Alzheimer’s disease
by: Waimao Gao, et al.
Published: (2025-02-01) -
Pharmacological Mechanism of Zuojin Pill for Gastroesophageal Reflux Disease: A Network Pharmacology Study
by: Mi Lv, et al.
Published: (2022-01-01) -
Berberine-induced browning and energy metabolism: mechanisms and implications
by: Aslıhan Alpaslan Ağaçdiken, et al.
Published: (2025-02-01) -
Advance in identified targets of berberine
by: Penghai Sun, et al.
Published: (2025-01-01)